BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11376317)

  • 1. Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study.
    Wassmuth R; Lentzsch S; Erdbruegger U; Schulz-Menger J; Doerken B; Dietz R; Friedrich MG
    Am Heart J; 2001 Jun; 141(6):1007-13. PubMed ID: 11376317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer].
    Oberholzer K; Kunz RP; Dittrich M; Thelen M
    Rofo; 2004 Sep; 176(9):1245-50. PubMed ID: 15346258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome.
    Wassmuth R; Göbel U; Natusch A; Schneider W; Kettritz R; Dietz R; Luft FC; Schulz-Menger J
    J Card Fail; 2008 Dec; 14(10):856-60. PubMed ID: 19041050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging.
    Ripa RS; Nilsson JC; Wang Y; Søndergaard L; Jørgensen E; Kastrup J
    Am Heart J; 2007 Nov; 154(5):929-36. PubMed ID: 17967600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction.
    Yang Z; Berr SS; Gilson WD; Toufektsian MC; French BA
    Circulation; 2004 Mar; 109(9):1161-7. PubMed ID: 14967719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of myocardial function and perfusion by MRI two days and four months after acute myocardial infarction revascularised by primary angioplasty].
    Noël B; Morice MC; Kokis A; Garot J; Dumas P; Louvard Y; Tavolaro O; Lévy M; Lefèvre T
    Arch Mal Coeur Vaiss; 2007 Sep; 100(9):729-35. PubMed ID: 18032999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonance.
    Jordan JH; D'Agostino RB; Hamilton CA; Vasu S; Hall ME; Kitzman DW; Thohan V; Lawrence JA; Ellis LR; Lash TL; Hundley WG
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):872-9. PubMed ID: 25273568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late enhancement detected by cardiac magnetic resonance imaging in acute myocarditis mimicking acute myocardial infarction: location patterns and lack of correlation with systolic function.
    Camastra GS; Cacciotti L; Marconi F; Sbarbati S; Pironi B; Ansalone G
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1029-33. PubMed ID: 18163015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
    Mercuro G; Cadeddu C; Piras A; Dessì M; Madeddu C; Deidda M; Serpe R; Massa E; Mantovani G
    Oncologist; 2007 Sep; 12(9):1124-33. PubMed ID: 17914082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of myocardial scarring on nonstress delayed-contrast-enhancement cardiac magnetic resonance imaging correlates directly with degrees of resting regional dysfunction in chronic ischemic heart disease.
    Srichai MB; Schvartzman PR; Sturm B; Kasper JM; Lieber ML; White RD
    Am Heart J; 2004 Aug; 148(2):342-8. PubMed ID: 15309007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies.
    Auner HW; Tinchon C; Linkesch W; Tiran A; Quehenberger F; Link H; Sill H
    Ann Hematol; 2003 Apr; 82(4):218-22. PubMed ID: 12679885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hyperenhancement on delayed contrast-enhanced magnetic resonance imaging is the characteristic sign after coronary microembolization.
    Ma JY; Qian JY; Jin H; Chen ZW; Chang SF; Yang S; Sun AJ; Zeng MS; Zou YZ; Ge JB
    Chin Med J (Engl); 2009 Mar; 122(6):687-91. PubMed ID: 19323935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
    Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?].
    Erlaky H; Tóth K; Szabolcs J; Horváth E; Kemény V; Müller J; Csóka M; Jókúti L; Erdélyi D; Kovács G
    Magy Onkol; 2006; 50(1):25-32. PubMed ID: 16617380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.
    Britten MB; Abolmaali ND; Assmus B; Lehmann R; Honold J; Schmitt J; Vogl TJ; Martin H; Schächinger V; Dimmeler S; Zeiher AM
    Circulation; 2003 Nov; 108(18):2212-8. PubMed ID: 14557356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography].
    Hunold P; Brandt-Mainz K; Freudenberg L; Vogt FM; Neumann T; Knipp S; Barkhausen J
    Rofo; 2002 Jul; 174(7):867-73. PubMed ID: 12101477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
    Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
    Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality.
    Yan AT; Shayne AJ; Brown KA; Gupta SN; Chan CW; Luu TM; Di Carli MF; Reynolds HG; Stevenson WG; Kwong RY
    Circulation; 2006 Jul; 114(1):32-9. PubMed ID: 16801462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed enhancement morphology on cardiac magnetic resonance imaging is correlated with signal-averaged electrocardiogram and QT dispersion in myocardial infarction.
    Takase B; Nagata M
    Angiology; 2009; 60(4):412-8. PubMed ID: 19124453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.